According to Innoviva's latest financial reports the company has $0.67 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $0.67 B | 19.29% |
2022-12-31 | $0.56 B | 7.58% |
2021-12-31 | $0.52 B | -13.47% |
2020-12-31 | $0.60 B | 77.67% |
2019-12-31 | $0.34 B | 115.1% |
2018-12-31 | $0.15 B | -165.53% |
2017-12-31 | $-0.25 B | -31.24% |
2016-12-31 | $-0.36 B | 3.02% |
2015-12-31 | $-0.35 B | 53.41% |
2014-12-31 | $-0.23 B | -174.67% |
2013-12-31 | $0.29 B | 92.95% |
2012-12-31 | $0.15 B | -278.09% |
2011-12-31 | $-87.06 M | 288.28% |
2010-12-31 | $-22.42 M | -88.14% |
2009-12-31 | $-0.19 B | 40.05% |
2008-12-31 | $-0.14 B | 103.65% |
2007-12-31 | $-66.27 M | -204.67% |
2006-12-31 | $63.31 M | 6.25% |
2005-12-31 | $59.58 M | -68.7% |
2004-12-31 | $0.19 B | -163.55% |
2003-12-31 | $-0.3 B | 29.16% |
2002-12-31 | $-0.24 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $1.38 B | 105.82% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $14.51 M | -97.85% | ๐บ๐ธ USA |